Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
---|---|
Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
ClinicalTrials.gov Identifier: | NCT00005717 |
To test the effectiveness of a self-management program for chronic obstructive disease (COPD) patients. The program to improve adherence could be conducted by nurses or other clinic staff in settings where comprehensive rehabilitation services were not available.
Condition |
---|
Lung Diseases, Obstructive Bronchitis Emphysema Chronic Obstructive Pulmonary Disease |
Study Type: | Observational |
Study Design: | Natural History, Longitudinal |
Study Start Date: | August 1990 |
Estimated Study Completion Date: | July 1995 |
BACKGROUND:
In 1990, the available data on medication adherence among chronic obstructive pulmonary disease (COPD) patients consistently indicated that adherence was a significant problem. This was a particularly distressing finding, considering that pharmacological therapy was considered the backbone of COPD management in settings where comprehensive rehabilitation services were limited. Despite the importance of this issue and a large data base on how to enhance medication adherence among medical populations, there had been no empirical investigations evaluating the implementation of these strategies with COPD patients.
DESIGN NARRATIVE:
The prospective, controlled study randomized 230 emphysema and chronic bronchitis patients from an urban university medical center into either a "usual care", control group or into a self-management skills training program for improving adherence. The training program was based on self-management procedures for enhancing adherence which had proven efficacious with diverse populations.
Self-reported and objective measures of adherence were examined during the two month baseline period and the one year follow-up in the controlled study.
A range of possible covariates including demographics, patient characteristics, treatment, and therapeutic outcome variables were also collected during the baseline phase and at the 6-month and 12-month follow-up visits in the controlled study to evaluate their relationship to the observed adherence levels.
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
No eligibility criteria
Study ID Numbers: | 4926 |
Study First Received: | May 25, 2000 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00005717 History of Changes |
Health Authority: | United States: Federal Government |
Pulmonary Emphysema Emphysema Lung Diseases, Obstructive Respiratory Tract Infections Respiratory Tract Diseases |
Bronchial Diseases Lung Diseases Bronchitis Pulmonary Disease, Chronic Obstructive |
Emphysema Lung Diseases, Obstructive Pathologic Processes Respiratory Tract Infections Respiratory Tract Diseases |
Bronchial Diseases Lung Diseases Bronchitis Pulmonary Disease, Chronic Obstructive |